Related Experiment Video
Updated: Jul 13, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Status of uric acid management in hypertensive subjects
Yasutaka Yamamoto1, Koichi Matsubara, Go Igawa
1Division of Regenerative Medicine and Therapeutics, Tottori University Graduate School of Medical Sciences, Yonago, Japan. yasutaka@grape.med.tottori-u.ac.jp
Insights
Hyperuricemia is common in hypertensive patients, particularly men. While doctors monitor uric acid, intensive management and treatment are lacking, increasing cardiovascular disease risk.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- Hyperuricemia is a known risk factor for cardiovascular diseases (CVDs) in hypertensive individuals.
- Effective management of serum uric acid levels is crucial for CVD prevention in this population.
Purpose of the Study:
- To investigate the current status of uric acid management in hypertensive patients.
- To identify factors associated with hyperuricemia and assess treatment adherence and target achievement.
Main Methods:
- A study involving 799 hypertensive patients (mean age 70.9 years) and 43 physicians.
- Analysis of serum uric acid levels, prevalence of hyperuricemia, and medication use.
- Comparison of management strategies across different patient demographics and physician specialties.
Main Results:
- Hyperuricemia prevalence was 17.5%, higher in men and associated with specific comorbidities and lifestyle factors.
- Serum uric acid levels were elevated in men and patients with heart failure, renal dysfunction, high triglycerides, low HDL, smokers, and those on beta-blockers.
- Only 50% of hyperuricemic patients received medication, with less than half achieving the target level (6 mg/dL).
Conclusions:
- Despite high physician awareness, uric acid management in hypertensive patients is suboptimal.
- Intensive intervention and tailored treatment strategies are needed to improve outcomes and reduce CVD risk.
- Enhanced attention to uric acid monitoring and management is essential for hypertensive individuals.
Abstract:
Hyperuricemia in hypertensive subjects has been considered one of risk factors of cardiovascular diseases. We investigated the status of uric acid management in 799 hypertensive subjects (432 females and 367 males; mean age 70.9 years) managed by 43 doctors (19 cardiologists and 24 noncardiologists; 25 private practice doctors and 18 hospital doctors). The serum uric acid level was available in 85.7% of the patients. This availability was equivalent regardless of facility size, and more cardiologists than noncardiologists monitored this information. The prevalence of hyperuricemia was 17.5% and was higher in men and in patients with high triglyceridemia, left ventricular hypertrophy, renal dysfunction, proteinuria, and smokers, but was not higher in subjects with chronic heart failure, diabetes mellitus, and those with prescriptions for diuretics and beta-blockers. The average serum uric acid level was higher in men and patients with chronic heart failure, renal dysfunction, high triglyceridemia, low high-density cholesterolemia, smokers, and subjects prescribed beta-blockers. Fifty percent of hyperuricemic patients were medicated, and 48.6% of them cleared the uric acid target level (6 mg/dL). No differences were observed in the treatment rate or the achievement rate of the target between genders, concurrent diseases, and physician specialties. Although doctors, especially cardiologists, have a high concern for the serum uric acid level, they do not intervene intensively, and specific treatment for individual patterns is not routinely given. Thus, more attention to uric acid management is necessary in hypertensive subjects to prevent cardiovascular diseases.
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Antihypertensive Drugs: Action of Diuretics
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Urinary Tract Calculi III: Medical Management